Open Access
Sciences of Pharmacy
e-ISSN 2830-7259 | p-ISSN 2830-7046
DOI 10.58920/sciphar
Cite Score
0.5
e-ISSN 2830-7259 | p-ISSN 2830-7046
DOI 10.58920/sciphar
Cite Score
0.5
Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript.
Publication on SciPhar is free of charge at any stage. After acceptance, all papers are instantly templated and published online, with an average editorial process time of 1-7 days. Sciphar has 4 issues in each year.
[The reasons for prompt rejection of certain review articles can be found in the author instructions. Please familiarize yourself with the guidelines before submitting]
Scope
Sciphar covers all aspects of pharmacy, including but not limited to:
Contact us at our official email: sciphar@etflin.com
Our esteemed editorial board comprises 38 experts from 13 different countries. Our board members bring a diverse range of knowledge, skills, and experiences to the table, enabling us to provide a broad perspective on various issues.
Scopus ID Google Scholar ResearchGate
ORCID Google Scholar Scopus ID Research Gate
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
ResearchGate Google Scholar ORCID Scopus ID
ORCID Scopus ID ResearchGate Google Scholar
Mohd Shahezwan Abd Wahab, M.Clin.Pharm., Ph.D.
Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam, Malaysia
Expertise: Clinical Pharmacy; Hospital Pharmacy; Pharmacy Education; Complementary & Alternative Medicine; Pharmaceutical Care; Community Pharmacy; Medication Therapy Management
ResearchGate Google Scholar Scopus ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Expertise: Telemedicine; Ocular therapy; Stem cell therapy; Regenerative medicine for ocular diseases
apt. Fatma Aldila, S.Farm., M.I.P.H. M.H.M (Exn.)
Department of Clinical Studies, PT. Nalagenetik Riset Indonesia, Indonesia
Expertise: Pharmacoepidemiology; Pharmacoeconomics; Digital health; Medication safety; Health workforce
Google Scholar ResearchGate ORCID
Angi Nadya Bestari, S.Farm., M.Sc., Apt.
Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta 55281, Indonesia
Google Scholar
Keerthic Aswin, M.Pharm
CSIR-GATE JRF, Institute of Genomics and Integrative Biology, New Delhi, India
Google Scholar Scopus ID Research Gate
SOLYUR pharmaceutical company, Moscow 115432, Russia
Alert: We do not accept any paper generated by AI. A review paper should contain a discussion of previous works, criticism, comments, suggestions, and opinions of the experts (authors) supported by table(s) (previous work list and summary), figure(s) (chart, illustration, etc), and other investing data. Prompt rejection will be given if these criteria are not met.
"AI allowed, wisdom applied."
We use a submission system that can be accessed by registering an account through the Login button (top right).
We encourage the author to use this template (Download Template). All instructions are within the template, and it is easy to follow. Original Article must contain these sections: Abstract, Introduction, Experimental Section, Results, Discussion (can be combined with results), and Conclusion. Any structure is acceptable for other types of manuscripts as long as it contains: an Abstract, Introduction/Background, and Conclusion/Summary (a summary can be included within the discussion section).
SciPhar accepts original articles, reviews, mini-review, book-review, technical notes, case reports, case series, clinical trials, opinions/perspectives, conference proceedings, and pictorial essays. Author may submit or suggest another type of scientific manuscript.
If you use our template, then you can easily set up the font style. We use the Segoi UI font style with font size as follows:
The title must be clear and represent the whole manuscript content. The maximum title's length is three lines in the manuscript template. Only abbreviations use if the full term is included. We use 'Title Capitalization' rules for the paper title; check this good explanation and this APA style for title case rules.
Put a number after the author's name according to the affiliation number. If all authors are from the same affiliation, the number after the author's name is not necessary. The corresponding author should be marked with (*) after his/their name. Please provide all the corresponding emails if you have more than one corresponding author.
Please don't include titles, degrees, or statuses in the authorship information. While we hold the utmost respect for academic achievements, our goal is to promote equality in publishing, valuing the work of both young and senior researchers. These statuses could also change over time.
ORCID logo should only be used if you have an ORCID account and link the logo to your ORCID link. You can also input your ORCID ID (not the entire link, e.g., 0000-0000-0000-0000) in the authorship input during submission, and we will add your ORCID to the final version of the published PDF.
Unstructured abstract, at most 250 words. The abstract should briefly highlight the background, methods, results, and conclusions of the study.
Provide 3-6 unique and diverse keywords. One keyword must not exceed three words, and using abbreviations in keywords should be avoided. Choose keywords that highlight the crucial aspects of your work, excluding those already mentioned in the article title or extensively covered in the abstract. Keywords play a significant role in enhancing the visibility of your work in search engines. Therefore, using unique and distinct keywords from the title and abstract allows for a broader and more specific search scope for your work.
The graphical abstract ought to present a smooth and coherent overview of the entire research process. Rather than integrating it into the manuscript, please submit the graphical abstract separately. Note that the graphical abstract will only be accessible in the HTML version of the published article.
Quality: Minimum 300 dpi
Although optional, our editor may find your graphical abstract appealing and choose it as the issue cover.
The figure must be clear and labeled. All figures must be included in the manuscript file and positioned as mentioned in the text for the first time. Please use bold for the figure number, for example, Figure 1. Flowchart of the methodology. Ensure that you place a period (.) at the end of each caption for figures and tables.
To ensure clarity of the text and image in the figure, it is crucial to maintain the original aspect ratio when scaling up a figure. Stretching or widening the figure on only one side may cause blurriness and, therefore, should be avoided.
To reproduce a figure (already published in a paper in any journal) in SciPhar, copyright permission must be obtained. If a figure is reproduced without permission, it will be considered plagiarism, and the authors will be asked to rectify it. A note like 'copyright has been obtained from Einstein et al.' must be included within the Figure legend.
Tables must be created with the insert table feature of Microsoft Word. Please do not insert a table as an image. All borders must be visible. The table header must be bold. The table number in the caption must also be bold. Ensure that you place a period (.) at the end of each caption for figures and tables.
Example: Table 1. Patients’ characteristics.
If a table extends beyond three pages, it must be submitted as a supplemental table in EXCEL format or another data table file. However, the extra table should still be mentioned in the text of the article to maintain its relevance and clarity.
To ensure accessibility and ease of use, supplemental data can be shared as a file (ZIP or RAR) submitted with the manuscript or a permanent link to the data storage location. For additional data in the form of programs or applications, we recommend using GitHub. It is not acceptable to store the data on a personal cloud account like Gdrive or Onedrive.
Equations must be created with the insert equation feature of Microsoft Word.
Please use dots as a decimal marker, not commas.
The use of Grammarly is encouraged to minimize grammatical errors. Grammarly can be downloaded, installed, and added to the Microsoft Word document.
Authors are encouraged to use software such as Mendeley, Zotero, etc., to arrange the references. Mendeley and Zotero can be downloaded and installed. Once installed, they will appear on the 'References' tab on the Microsoft Word document.
We accept the Vancouver style.
Please include funding information in your manuscript if you receive one. The full name of the funding agency and the grant number must be included.
In terms of planning the study design, data analysis, statistical analysis, software, executing work, writing, and editing, a significant contribution should be made by all contributing authors, such as the first author, co-authors, and corresponding authors. Authors are encouraged to get familiar with the Committee on Publication Ethics (COPE) guidelines.
The corresponding author will be responsible for communicating with the editors from the initial submission till publication. Depending on the requirement, there may be two corresponding authors. In the case of two corresponding authors, the asterisk '*' sign should accompany their names in the manuscript, and the initials of the authors should accompany their email addresses in the manuscript.
During the review process, the corresponding author may request that the authorship be changed, providing appropriate reasons for the request. It is not permitted to add or remove authors once a submission has been accepted.
If possible, authors are requested to submit a plagiarism report from commercial software (or from an accessible online server) as supplemental data. For all types of articles, the plagiarism percentage should be kept as low as possible (maximum upper limit 15% excluding references). Even if the plagiarism percentage remains below 15%, the authors may be further asked to reduce the plagiarism to increase the manuscript's authenticity.
Studies should be carried out keeping in mind the standard guidelines set by OECD, CPCSEA, ICH, Animal Welfare Board of India, as well as other organizations. Ethical clearance with proper documents should be obtained from the concerned authority (for example, Institutional Animal Ethics Committee) to conduct the studies. Also, sufficient details regarding the document number should be mentioned in the manuscript.
Retraction guidelines provided by the Committee on Publication Ethics (COPE) will be followed. A retraction notice will be given to a paper if the findings are unreliable, unethical, plagiarized, or manipulated. To maintain integrity, the retracted paper will remain visible on the e-bulletin page. However, a notice of retraction will accompany the article.
Kindly submit all the files requested through the user panel. Any modifications or revisions made to the manuscript should be marked in yellow or with red font color. To address the comments from the reviewers, please prepare and upload a rebuttal letter that includes a response to each word. Including references based on reviewer suggestions is not mandatory. After going through the galley proof process, the manuscript's content cannot be changed anymore. It is imperative for the author(s) to thoroughly review all data (authorship, title, and other metadata) and content within the manuscript before approving the galley proof.
Dr Bunu Khatiwara (Google Scholar)
Al Ameen College of Pharmacy
Dr Chisom Finian Iroka (Google Scholar)
Department of Botany, Nnamdi Azikiwe University, Awka, Nigeria
Prof Archana S. Patil (Google Scholar)
Department of Pharmaceutics, KLE University’s College of Pharmacy, Nehru Nagar, Belagavi 590010, Karnataka, India
Dr Ahmed Abd El-Moniem El-Sayed Amer (Google Scholar)
Department of Pharmacy, Damanhur Military Hospital.
Dr Faruk Jayanto Kelutur (Google Scholar)
Department of Chemistry, Pattimura University, Ambon, Indonesia
Prof Quratulane Gillani (Google Scholar)
Assistant Professor, The Women University Multan, Pakistan
Dr Adhe Septa Ryant Agus (Google Scholar)
STIKes Dirgahayu Samarinda
Dr May Thazin Thant (Google Scholar)
University of Pharmacy, Yangon
Dr Ratri Rokhani (Google Scholar)
Pharmacology Laboratory, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas 53182, Indonesia
Dr Irma Rahayu Latarissa (Google Scholar)
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia
Dr Shouvik Kumar Nandy (Google Scholar)
Assistant Professor in Pharmacology at Burdwan Institute of Pharmacy, Purba Barddhaman 713103, India
Dr Ejiofor InnocentMary IfedibaluChukwu (Google Scholar)
Department of Pharmacognosy and Traditional Medicine, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka-420110
Dr Ridho Islamie (Google Scholar)
Departemen Farmasi Klinis dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Surabaya 60293, Indonesia
Dr Nur Rasdianah (Google Scholar)
Pharmacy Study Program, Faculty of Health and Sports, Universitas Negeri Gorontalo, Gorontalo 96128, Indonesia
Dr Mark Danquah (Google Scholar)
Departmentof Pharmaceutical Sciences, Faculty of Applied Science and Technology, Sun-yani Technical University, Sunyani, Ghana
Dr Yuniarti Falya (Google Scholar)
Sekolah Tinggi Farmasi Muhammadiyah Cirebon, Indonesia
Dr Bachtiar Rivai (Google Scholar)
Pharmaceutical Science and Technology, Chulalongkorn University, Bangkok, 10330, Thailand
Dr Mrinmoy Chakraborty (Google Scholar)
Department of Pharmaceutical Science, Kumaun University, Nainital 263002, India
Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Dr Elizaveta Valeryevna Melnik (Google Scholar)
Department of Pharmaceutical and Toxicological Chemistry named after A.P. Arzamastsev, Sechenov University
Dr apt. Erma Yunita, M.Sc. (Google Scholar)
Akademi Farmasi Indonesia, Yogyakarta, Indonesia
Dr Mia Nisrina Ambar Fatin (Google Scholar)
Fakultas Farmasi, Universitas Bhakti Kencana, Bandung, Indonesia
Dr Sk Mizanul Haque (Google Scholar)
Department of Scientometrics, Library and Information Sciences, University of Calcutta, Kolkata, India
Dr Agus Rusdin (Google Scholar)
Department of Pharmacy, Bandung Health Polytechnic, West Java, Indonesia.
Dr Lalrinmawii (Google Scholar)
Medical Officer at Keitum Health & Wellness Centre under National Ayush Mission, Government of India
Dr Hardika Aditama (Google Scholar)
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
Dr James H. Zothantluanga (Google Scholar)
Dibrugarh University
Dr Iksen (Google Scholar)
Departemen Farmasi,
Sekolah Tinggi Ilmu Kesehatan Senior Medan,
Dr Muhammad Fauzi (Google Scholar)
Departement of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
Any enquiry related to the journal, please reach us through email below.
Sciences of Pharmacy editorial's email: sciphar@etflin.com
Office: Sungai Manonda Street, Duyu, Tatanga,
Palu City 94225, Indonesia.
WhatsApp: +62 82216335184
Publisher email: halo@etflin.com
All papers published in the journal are freely accessible immediately after publication. The papers are freely available to read, shared, and reproduced in any form with proper citation to the original work. Open access is a property of individual works and community standards that will enforce proper attribution and responsible use of the published work.
Publishing a paper in the journal is free. The journal do not take submission fees, editorial processing charges, article processing charges, page charges, or color charges.
The journal is licensed under the Creative Commons Attribution (CC BY) 4.0 International License.
The authors retain the copyright © of their published works. However, the published work of the
authors can be read, downloaded, shared, and cited with proper reference to the original work.
You may read this article for a better Understanding of Copyright.
Research Article
Open Access
Tuesday, 5 September 2023
Adilah Marwa et al.
More
Research Article
Open Access
Monday, 28 August 2023
Tunde Ayobami Owolabi et al.
More
Research Article
Open Access
Saturday, 5 August 2023
Mus'ab Usman Abba et al.
More
Review
Open Access
Friday, 14 July 2023
Subha Ranjan Das et al.
More
Research Article
Open Access
Thursday, 6 July 2023
Hiteswar Saikia et al.
MoreCite Score
0.5
"Efficacy of sunscreen gel infused with giant tiger prawn (Penaeus monodon) head extract"
Read more"Comparison of Microsampling and Conventional Sampling Techniques for Quantification of Warfarin in Blood Samples: A Systematic Review"
Read more"In Silico Studies of Drug Discovery and Design Against COVID-19 Focusing on ACE2 and Spike Protein Virus Receptors: A Systematic Review"
Read more
Mini Review
Open Access
Monday, 27 June 2022
Quality By Design: Approach to Analytical Method ValidationMayang Kusuma Dewi et al.
Review
Open Access
Sunday, 26 June 2022
Method and Critical Aspect of Semisolid MixingMeylani Sutoro et al.
Opinion/Perspective
Open Access
Tuesday, 28 June 2022
Impact of Preparation Method in Co-Amorphous SystemAmelia Soyata et al.
Research Article
Open Access
Monday, 20 February 2023
Antihyperlipidemic and Antioxidant Activities of Ethanolic Extract of Paederia foetida Leaves (EEPFL) in Albino RatsBikram Dutta Tassa et al.
Research Article
Open Access
Saturday, 5 August 2023
Exploring the Antiepileptic Potential of Amaranthus spinosus: An Experimental Study in Albino MiceMus'ab Usman Abba et al.
As a publisher, we create, store, and utilize cookies to enhance the features and services we provide. Several necessary cookies are implemented as part of the website's functionality.
_ga | etflin.com
The purpose of this cookie, set by Google Analytics, is to track the number of site visitors by remembering whether or not you have previously visited our website.
The following cookies are utilized to identify and authenticate users. By utilizing our service and registering an account within our system, you are consenting to the use of the following cookie. We do not share this data to any third party.
username | etflin.com
We employ this cookie to recognize users who have logged into the user system, ensuring that the data you manage is labeled with your username.
email | etflin.com
Email is utilized as our communication tool to send notifications, conduct initial registration verification, and account filtering.
name | etflin.com
We utilize your name to display on the website menu, indicating that you have successfully logged into the system.
token | etflin.com
We use a token to authenticate and identify your login session.
We Computerize Sciences, We Publish Sciences, We Are Scientist
ETFLIN
